A. Parrott

发表

Nesbitt's Paradox resolved? Stress and arousal modulation during cigarette smoking.

A. Parrott, A C Parrott, 1998, Addiction.

A short self-report measure of problems with executive function suitable for administration via the Internet

A. Scholey, T. Buchanan, A. Parrott, 2010, Behavior research methods.

Heightened Stress and Depression Follow Cigarette Smoking

A. Parrott, 2004, Psychological reports.

Nonequivalence of on-line and paper-and-pencil psychological tests: The case of the prospective memory questionnaire

Tom Buchanan, Andrew C. Parrott, A. Scholey, 2005, Behavior research methods.

MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users

A. Parrott, 2013, Neuroscience & Biobehavioral Reviews.

The Effects of MDMA and Methamphetamine on Car Driving Simulator Performance, Cognitive Skills, and Mood States

K. Wesnes, A. Parrott, C. Stough, 2011 .

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

A. Parrott, J. Lasky, 1998, Psychopharmacology.

Effects of alcohol on subjective ratings of prospective and everyday memory deficits.

A. Scholey, T. Buchanan, A. Parrott, 2003, Alcoholism, clinical and experimental research.

Patterns of Drug Use and the Influence of Gender on Self-Reports of Memory Ability in Ecstasy Users: A Web-Based Study

A. Scholey, T. Buchanan, A. Parrott, 2003, Journal of psychopharmacology.

Differential effects of Ecstasy and cannabis on self‐reports of memory ability: a web‐based study

A. B. Scholey, A. Scholey, T. Buchanan, 2001, Human psychopharmacology.

The effects of clobazam upon critical flicker fusion thresholds: A review

A. Parrott, A. Parrott, 1982 .

Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes

A. Parrott, L. Young, 2014, Temperature.

Explaining the stress‐inducing effects of nicotine to cigarette smokers

A. Parrott, Rachel Murphy, 2012, Human psychopharmacology.

Smoking deprivation and cigarette reinstatement: effects upon visual attention

A. Parrott, G. Roberts, A. Parrott, 1991, Journal of psychopharmacology.

The effects of cigarette smoking and abstinence on auditory verbal learning

A. Parrott, Husna Begum, L. Dawkins, 2008, Human psychopharmacology.

Individual differences in stress and arousal during cigarette smoking

A. Parrott, 1994, Psychopharmacology.

Nicotine Polacrilex Gum and Sustained Attention

A. Parrott, D. Craig, M. Haines, 1991 .

MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users

A. Parrott, C. Roberts, B. Quednow, 2018, Neuroscience and Biobehavioral Reviews.

Hair MDMA Samples Are Consistent with Reported Ecstasy Use: Findings from a Study Investigating Effects of Ecstasy on Mood and Memory

A. Scholey, T. Buchanan, A. Parrott, 2010, Neuropsychobiology.

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

A. Parrott, 2004, Psychopharmacology.

Individual differences in stress and arousal

A. Parrott, 1994 .

Acute pharmacodynamic tolerance to the of cigarette smoking

A. Parrott, 1994 .

Alcohol: drink less and live more.

A. Parrott, 2016 .

Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users

A. Scholey, T. Buchanan, A. Parrott, 2003, Psychopharmacology.

The Psychobiological Problems of Continued Nicotine Dependency in E-Cigarette ‘Vapers’. Commentary: “Electronic Cigarettes”

A. Parrott, 2015, Front. Psychiatry.

MDMA: Neurohormonal, Neurocognitive, and Psychobiological Aspects of Recreational Ecstasy

A. Scholey, A. Parrott, R. Bruno, 2009 .

Does cigarette smoking cause stress

A. Parrott, 1999 .

Transdermal scopolamine: Effects of single and repeated patches upon aspects of vision

A. Parrott, A. Parrott, 1986 .

Daily uplifts, hassles, stresses and cognitive failures: in cigarette smokers, abstaining smokers, and non-smokers.

A. Parrott, F. J. Kaye, Andrew C. Parrott, 1999, Behavioural pharmacology.

Stress and arousal in sedative and stimulant cigarette smokers

A. Parrott, S. O'Neill, 2005, Psychopharmacology.

Smoking cessation leads to reduced stress, but why?

A. Parrott, 1995, The International journal of the addictions.

Effects of transdermal scopolamine upon psychological test performance at sea

A. Parrott, R. Jones, 2004, European Journal of Clinical Pharmacology.

Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning.

A. Parrott, 1989, Aviation, space, and environmental medicine.

Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users

E. Gouzoulis-Mayfrank, A. Parrott, J. Daumann, 2007, Journal of Neural Transmission.

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects

N. Solowij, A. Parrott, J. Rodgers, 2004 .

Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects

N. Solowij, A. Parrott, J. Rodgers, 2004, Journal of psychopharmacology.

Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users

A. Parrott, 2003, Human psychopharmacology.

Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications.

L. Downey, A. Parrott, A. Hayley, 2018, Current drug abuse reviews.

A. Burgess, L. Venables, A. Parrott, 2011, Psychopharmacology.

Anabolic steroid use by amateur athletes: effects upon psychological mood states.

A. Parrott, P. Choi, M. Davies, 1994, The Journal of sports medicine and physical fitness.

Drug taking - for better or for worse?

A. Parrott, 2008 .

Cigarette smoking does cause stress.

A. Parrott, 2000, The American psychologist.

MDMA and 5‐HT neurotoxicity: the empirical evidence for its adverse effects in humans – no need for translation

A. Parrott, 2012, British journal of pharmacology.

Ecstasy versus alcohol: Tolstoy and the variations of unhappiness

A. Parrott, 2007, Journal of psychopharmacology.

Stress and arousal in sedative and stimulant

A. Parrott, S. O'Neill, 1992 .

Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors

A. Parrott, K. Soar, J. Turner, 2006, Journal of psychopharmacology.

The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.

D. Blazer, A. Parrott, A. Patkar, 2009, Addictive behaviors.

Cigarette-Derived Nicotine is not a Medicine

A. Parrott, 2003, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Cigarette smoking: effects upon self-rated stress and arousal over the day.

A. Parrott, 1993, Addictive behaviors.

Acute pharmacodynamic tolerance to the subjective effects of cigarette smoking

A. Parrott, 1994, Psychopharmacology.

Stress modulation over the day in cigarette smokers.

A. Parrott, Andrew C. Parrott, 1995, Addiction.

Does cigarette smoking cause stress?

A. Parrott, A C Parrott, 1999, The American psychologist.

Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects

L. Downey, A. Parrott, A. Hayley, 2017, Human psychopharmacology.

One-Year Outcomes of Prenatal Exposure to MDMA and Other Recreational Drugs

Lynn T Singer, A. Parrott, D. Moore, 2012, Pediatrics.

Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users

M. Blagrove, A. Parrott, Katy A Jones, 2009, Journal of psychoactive drugs.

Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects

K. Wesnes, K. Wesnes, A. Parrott, 2004, Psychopharmacology.

The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance

A. Parrott, 2004, Psychopharmacology.

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress

A. Parrott, 2006, Journal of psychopharmacology.

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users

T. Buchanan, A. Parrott, T. Heffernan, 2002, Human psychopharmacology.

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

A. Parrott, 2001, Human psychopharmacology.

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

A. Parrott, J. Turner, J. Turner, 2000, Drug and alcohol dependence.

Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research

A. Parrott, 2013, Human psychopharmacology.

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

Andy C. Parrott, Raffaella M. Milani, Rishee Parmar, 2001, Psychopharmacology.

Running Head Right-hand : Management of Conditions Caused by MDMA Running Head Left-hand :

A. Parrott, 2019 .

MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans.

A. Parrott, Andrew C. Parrott, 2012, Drug and alcohol dependence.

Mephedrone and MDMA: A comparative review

A. Parrott, Jessica Mead, 2020, Brain Research.

The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.

D. Blazer, Chongming Yang, A. Parrott, 2009, The American journal on addictions.

Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users

R. Stickgold, M. Walker, M. Blagrove, 2011, Journal of psychopharmacology.

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

A. Parrott, A. C. Parrott, 2002, Pharmacology Biochemistry and Behavior.

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

A. Parrott, 2005, Journal of psychopharmacology.

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.

A. Scholey, T. Buchanan, A. Parrott, 2004, Addictive behaviors.

Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation

A. Parrott, 2015, Human psychopharmacology.

MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves

A. Parrott, A.C. Parrott, Andrew C. Parrott, 2004, Neuropsychobiology.

Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants

Brenda Tysse, Rory P Wilson, L. Downey, 2017, Journal of clinical pharmacology.

Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects

L. Downey, A. Parrott, R. Bruno, 2017, Journal of psychopharmacology.

Novel psychoactive substances: Shedding new lights on the ever‐changing drug scenario and the associated health risks

Z. Demetrovics, A. Parrott, O. Corazza, 2017, Human psychopharmacology.

Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’

A. Parrott, 2016, Behavioural pharmacology.

Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.

A. Parrott, D. Moore, Sarah E Fulton, 2016, Neurotoxicology and teratology.

Novel psychoactive substances: second and third international conferences

A. Parrott, 2015, Human psychopharmacology.

MDMA, cortisol, and heightened stress in recreational ecstasy users

A. Scholey, L. Downey, A. Parrott, 2014, Behavioural pharmacology.

Increased cortisol levels in hair of recent Ecstasy/MDMA users

T. Stalder, L. Downey, A. Parrott, 2014, European Neuropsychopharmacology.

Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy

A. Parrott, D. Moore, Sarah E Fulton, 2014, Journal of psychopharmacology.

The Potential Dangers of Using MDMA for Psychotherapy

A. Parrott, 2014, Journal of psychoactive drugs.

Novel psychoactive substances: first international conference

A. Parrott, O. Corazza, F. Schifano, 2013 .

Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.

A. Parrott, D. Moore, Sarah E Fulton, 2012, Neurotoxicology and teratology.

Cocaine vs Ecstasy/MDMA: Comparative Effects on Mood and Cognition in Recreational Users

A. Parrott, L. Evans, J. Howells, 2011 .

Conscious awareness versus optimistic beliefs in recreational Ecstasy/MDMA users

A. Parrott, 2010 .

During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study

Emma L. Axelsson, F. Braddick, A. Parrott, 2010, Journal of psychopharmacology.

Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users

A. Parrott, Andrew C. Parrott, 2009, Neuropsychobiology.

Dance Clubbing on MDMA and during Abstinence from Ecstasy/MDMA: Prospective Neuroendocrine and Psychobiological Changes

A. Parrott, C. Kissling, A. Conner, 2008, Neuropsychobiology.

Sleep, energy, and self rated cognition across 7 nights following recreational ecstasy/MDMA use.

A. Parrott, 2008 .

The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review

A. Parrott, 2007, Psychopharmacology.

Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users

A. Scholey, T. Buchanan, A. Parrott, 2006, Human psychopharmacology.

Persistent Neuropsychological Problems after 7 Years of Abstinence from Recreational Ecstasy (MDMA): A Case Study

A. Parrott, H. Fox, K. Soar, 2004, Psychological reports.

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

B. Sahakian, R. Rogers, A. Parrott, 2002, Psychopharmacology.

Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change

A. Parrott, 2000, Neuropsychobiology.

Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits

A. Lees, K. Wesnes, A. Parrott, 1998, Journal of psychopharmacology.

Smoking cessation in women: effects of the menstrual cycle.

A. Parrott, D. Craig, J. Coomber, 1992, The International journal of the addictions.

Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history

A. Parrott, K. Soar, J. Turner, 2001, Human psychopharmacology.

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

A. Parrott, H. Fox, J. Turner, 2001, Journal of psychopharmacology.

The reality of psychomotor problems, and the possibility of Parkinson’s disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003)

A. Scholey, T. Buchanan, A. Parrott, 2003, Psychopharmacology.

Does cigarette smoking increase stress?

A. Parrott, 1994, Addiction.

Ecstasy and the SCL-90 findings: a reply to Cole et al.

A. Parrott, R. Milani, J. Turner, 2002, Psychopharmacology.

Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’)

A. Parrott, M. Aguilar, M. P. García-Pardo, 2019, Brain Research.

Aesthetic Responses to a Series of Paintings by Paul Klee

A. Parrott, 1989 .

MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014)

A. Parrott, 2014, Human psychopharmacology.

Residual neurocognitive features of ecstasy use: a re-interpretation of Halpern et al. (2011) consistent with serotonergic neurotoxicity.

A. Parrott, 2011, Addiction.

Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs

A. Parrott, 2018, Brain sciences.

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self‐rated aggression and somatic symptoms

F. Schifano, A. Parrott, F. Schifano, 2005, Human psychopharmacology.

In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, crystal): preliminary findings.

A. Parrott, D. Moore, Sarah E Fulton, 2011, Clinics in developmental medicine.

5 – Smoking, Nicotine and Human Performance

K. Wesnes, A. Parrott, 1992 .

MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study

A. Scholey, A. Parrott, C. Stough, 2011, Psychopharmacology.

Nicotine chewing gum (2 mg, 4 mg) and cigarette smoking: comparative effects upon vigilance and heart rate

A. Parrott, A. C. Parrott, G. Winder, 2004, Psychopharmacology.

Diabetes management: Viewpoint of the patient

A. Parrott, 1990 .

Self-rated everyday and prospective memory abilities of cigarette smokers and non-smokers: a web-based study.

A. Scholey, T. Buchanan, A. Parrott, 2005, Drug and alcohol dependence.

Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research

A. Parrott, 2006, Psychopharmacology.

Developmental outcomes of 3,4‐methylenedioxymethamphetamine (ecstasy)‐exposed infants in the UK

A. Parrott, D. Moore, Sarah E Fulton, 2015, Human psychopharmacology.

MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy

A. Parrott, D. Moore, M. Min, 2014, Human psychopharmacology.

Psychological functions served by nicotine chewing gum.

A. Parrott, D. Craig, 1995, Addictive behaviors.

Adult attention deficit hyperactivity disorder and other psychiatric symptoms in recreational polydrug users

J. Thome, A. Parrott, R. Donev, 2012, Human psychopharmacology.

Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks.

A. Parrott, D. Craig, 1992, Neuropsychobiology.

Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users

A. Parrott, M. Stuart, Andrew C. Parrott, 1997 .

Wild state secrets: ultra‐sensitive measurement of micro‐movement can reveal internal processes in animals

Yuzhi Cai, Mark D. Holton, Brenda Tysse, 2014 .

Selective Neurocognitive Deficits Associated with Multiple Doses of Ecstasy/MDMA: A Reply to Cole

A. Parrott, H. Fox, 2003, Journal of psychopharmacology.

Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study

A. Parrott, Aimee L. May, 2015, Human psychopharmacology.

Personal constructs of anxiety under the 1,5-benzodiazepine derivative clobazam related to trait-anxiety levels of the personality

A. Parrott, R. Kentridge, 2004, Psychopharmacology.

‘Is MDMA a Human Neurotoxin?’:Diverse Views from the Discussants

A. Parrott, J. Turner, 2000, Neuropsychobiology.

A. Parrott, 2007, Human psychopharmacology.

Understanding Drugs and Behaviour

A. Scholey, A. Parrott, M. Moss, 2004 .

Scopolamine, cognition and dementia

A. Parrott, 1992, Journal of psychopharmacology.

International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16—21 July 2006 Ecstasy/MDMA and Memory Symposium

A. Scholey, I. McGregor, Tatia M.C. Lee, 2007, Journal of psychopharmacology.

Subject Index Vol. 60, 2009

B. Quinn, I. McGregor, J. Fisk, 2009, Neuropsychobiology.

Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study

Tom Buchanan, Tom Heffernan, Carol Pearson, 2006, Journal of psychopharmacology.

Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits

T. Stalder, L. Downey, A. Parrott, 2015, Human psychopharmacology.

Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users

P. Reed, A. Parrott, L. Jones, 2016, Journal of psychopharmacology.

Substance usage intention does not affect attentional bias: implications from Ecstasy/MDMA users and alcohol drinkers.

E. Pothos, A. Parrott, T. Wilcockson, 2019, Addictive behaviors.

Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users

A. Parrott, K. Soar, J. Turner, 2009, Journal of psychopharmacology.

Effects of a 1,5-benzodiazepine derivative upon performance in an experimental stress situation

A. Parrott, S. Davies, 2004, Psychopharmacology.

MDMA and LSD

A. Parrott, 2012 .

Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.

A. Parrott, R. Milani, H. Fox, 2004, Addictive behaviors.

Factor analysis of a sleep evaluation questionnaire

I. Hindmarch, A. Parrott, A. Parrott, 1978, Psychological Medicine.

Auditory verbal learning in drug‐free Ecstasy polydrug users

A. Parrott, H. Fox, A. Parrott, 2001, Human psychopharmacology.

Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.

A. Parrott, D. Moore, M. Min, 2012, Neurotoxicology and teratology.

Effects of Paintings and Music, Both Alone and in Combination, on Emotional Judgments

A. Parrott, 1982 .